Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -314,410 | -241,283 | -154,173 | -69,180 | -363,012 |
| Depreciation Amortization | 23,904 | 8,790 | 5,653 | 3,058 | 10,989 |
| Income taxes - deferred | -2,125 | -1,989 | -1,989 | -150 | -373 |
| Accounts receivable | -1,051 | -313 | 655 | 4,432 | -10,622 |
| Accounts payable and accrued liabilities | -3,677 | -8,556 | -1,241 | 728 | 10,221 |
| Other Working Capital | 3,799 | -2,364 | 2,598 | -469 | 7,451 |
| Other Operating Activity | 134,024 | 127,048 | 72,422 | 23,031 | 172,350 |
| Operating Cash Flow | $-159,536 | $-118,667 | $-76,075 | $-38,550 | $-172,996 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,528 | -3,840 | -970 | -21 | -28,482 |
| Net Acquisitions | -33,395 | -2,344 | -2,312 | N/A | -9,691 |
| Other Investing Activity | 0 | -22,325 | 0 | 0 | 0 |
| Investing Cash Flow | $-39,923 | $-28,509 | $-3,282 | $-21 | $-38,173 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 18,587 | 7,815 | 7,815 | 725 | 8,000 |
| Debt Issued | N/A | N/A | N/A | N/A | 17,411 |
| Debt Repayment | -55,000 | N/A | N/A | -59,533 | -3,074 |
| Common Stock Issued | 416,216 | 310,819 | 192,000 | 83,530 | 56,548 |
| Other Financing Activity | -205,564 | -132,819 | -131,853 | 0 | 0 |
| Financing Cash Flow | $174,239 | $185,815 | $67,962 | $24,722 | $78,885 |
| Exchange Rate Effect | 915 | 768 | 14 | 27 | -277 |
| Beginning Cash Position | 80,769 | 80,769 | 80,769 | 80,769 | 213,330 |
| End Cash Position | 56,464 | 120,176 | 69,388 | 66,947 | 80,769 |
| Net Cash Flow | $-24,305 | $39,407 | $-11,381 | $-13,822 | $-132,561 |
| Free Cash Flow | |||||
| Operating Cash Flow | -159,536 | -118,667 | -76,075 | -38,550 | -172,996 |
| Capital Expenditure | -6,528 | -3,840 | -970 | -21 | -28,482 |
| Free Cash Flow | -166,064 | -122,507 | -77,045 | -38,571 | -201,478 |